VSTM:NASDAQ
Verastem Inc
$7.44
arrow_downward
-1.46%(-0.11) 1D
$7.50
arrow_upward
+0.81% (+0.060)bedtimeAfter hours
Closed: Sep 18, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VSTM...
Open
$7.58
High
$7.84
Low
$7.40
Mkt. cap
673.79M
Avg. vol.
2.17M
Volume
4.50M
52-wk high
$10.82
52-wk low
$3.43
EPS
-$2.46
Beta
0.32
Shares outstanding
90.56M
No. of employees
102
Open
$7.58
High
$7.84
Low
$7.40
Mkt. cap
673.79M
Avg. vol.
2.17M
Volume
4.50M
52-wk high
$10.82
52-wk low
$3.43
EPS
-$2.46
Beta
0.32
Shares outstanding
90.56M
No. of employees
102
News stories
From web sources and news partners
marketscreener.com
·
17 hours ago
Verastem's Shares Not Fully Valuing its Growth Potential, RBC Says
CarePlus VietNam
·
1 month ago
VSTM Q1 2026 Earnings: Narrower-Than-Expected Loss Boosts Investor Confidence - Financial Health Score
CarePlus VietNam
·
2 months ago
Verastem Inc. (VSTM) Posts Modest Gain as Biotech Sector Sees Renewed Interest - ETF Flow
Profile
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
About Verastem Inc
CEOBrian Stuglik
Employees102
Founded2010
HeadquartersNeedham, Massachusetts, United States
SectorBiotechnology
Websiteverastem.com